-

Eurofins: Purchases of Own Shares From April 14th to April 17th 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins (Paris:ERF):

Name of the Issuer

Identity code of the Issuer

Day of the transaction

Identity code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC Code)

EUROFINS

529900JEHFM47DYY3S57

14/03/2025

FR0014000MR3

102,000

49.4276

XPAR

EUROFINS

529900JEHFM47DYY3S57

14/03/2025

FR0014000MR3

40,000

49.5281

CEUX

EUROFINS

529900JEHFM47DYY3S57

14/03/2025

FR0014000MR3

4,000

49.5201

TQEX

EUROFINS

529900JEHFM47DYY3S57

14/03/2025

FR0014000MR3

4,000

49.5274

AQEU

EUROFINS

529900JEHFM47DYY3S57

15/03/2025

FR0014000MR3

82,000

50.6996

XPAR

EUROFINS

529900JEHFM47DYY3S57

15/03/2025

FR0014000MR3

60,000

50.7077

CEUX

EUROFINS

529900JEHFM47DYY3S57

15/03/2025

FR0014000MR3

4,000

50.7073

TQEX

EUROFINS

529900JEHFM47DYY3S57

15/03/2025

FR0014000MR3

4,000

50.7053

AQEU

EUROFINS

529900JEHFM47DYY3S57

16/03/2025

FR0014000MR3

92,000

50.3874

XPAR

EUROFINS

529900JEHFM47DYY3S57

16/03/2025

FR0014000MR3

50,000

50.3402

CEUX

EUROFINS

529900JEHFM47DYY3S57

16/03/2025

FR0014000MR3

4,000

50.3603

TQEX

EUROFINS

529900JEHFM47DYY3S57

16/03/2025

FR0014000MR3

4,000

50.3629

AQEU

EUROFINS

529900JEHFM47DYY3S57

17/03/2025

FR0014000MR3

92,000

49.8205

XPAR

EUROFINS

529900JEHFM47DYY3S57

17/03/2025

FR0014000MR3

50,000

49.7377

CEUX

EUROFINS

529900JEHFM47DYY3S57

17/03/2025

FR0014000MR3

4,000

49.7823

TQEX

EUROFINS

529900JEHFM47DYY3S57

17/03/2025

FR0014000MR3

4,000

49.7699

AQEU

 

 

 

TOTAL

600,000

50.0809

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins

Eurofins

BOURSE:ERF
Release Versions
English

Contacts

Eurofins

More News From Eurofins

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF EUROFINS SCIENTIFIC SE – E1013 Identity of t...

Eurofins Medical Device Services Launches first GMP PFAS Screening and Testing Solutions for Medical Devices

LANCASTER, Pa.--(BUSINESS WIRE)--Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launched a GMP PFAS testing and screening solution, the first developed and commercialized for the medical device industry. This offering provides insights to medical device manufacturers as they navigate the complex and evolving global regulations surrounding PFAS, ultimately contributin...

Eurofins: Weekly Report on Share Repurchases From 24th November to 28th November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 24/11/2025 FR0014000MR3 20 000 58.4487 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/11/2025 FR0014000MR3 20 000 58.6804 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/1...
Back to Newsroom